Innovative Salmonella Vaccine Enhances Layer Performance

Egg producers in the UK are poised to benefit significantly from the latest advancement in poultry health with the approval of AviPro Salmonella Duo, the country’s first dual-strain Salmonella vaccine designed specifically for in-lay use. This new vaccine not only enhances the health of laying hens but also extends their immunity for up to 100 weeks, facilitating a shift towards longer laying cycles.

Transformative Benefits for Egg Production

The introduction of AviPro Salmonella Duo is set to revolutionize the egg production industry. With the ability to protect flocks against Salmonella contamination, producers can enjoy improved safety and productivity. Dr. Josh Davison, a veterinary technical consultant and brand manager at Elanco, emphasized that this breakthrough is a result of over 25 years of dedicated research and development.

Supporting Sustainable Practices

The vaccine’s extended efficacy aligns seamlessly with the industry’s increasing tendency to adopt longer production cycles. As producers aim for sustainability and efficiency, AviPro Salmonella Duo provides a robust solution to ensure the well-being of the birds while potentially lowering operating costs and waste.

Access Premium Insights

Get full access to all stories on Poultry World

This Premium article is exclusively available for subscribers

Obtain insights from exclusive interviews

Dive into articles covering trending industry topics

Get a glimpse into poultry farms worldwide

All the news is brought to you by experienced editors and experts from around the world

Nathalie
Kinsley

Fabian
Brockötter

Tony
McDougal